Global Medical Molecular Testing for Esophageal Cancer Market Insights, Forecast to 2029

Medical Molecular Testing for Esophageal Cancer Market

Market Analysis and Insights: Global Medical Molecular Testing for Esophageal Cancer Market

The global Medical Molecular Testing for Esophageal Cancer market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Medical Molecular Testing for Esophageal Cancer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Medical Molecular Testing for Esophageal Cancer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Medical Molecular Testing for Esophageal Cancer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Medical Molecular Testing for Esophageal Cancer include Amoy Diagnostics, Apexhealth, Berry Oncology, Genesis Health Group, Beijing Genetron Health Technology, InMedi, KingMed Diagnostics and United Gene International, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Medical Molecular Testing for Esophageal Cancer market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Medical Molecular Testing for Esophageal Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Medical Molecular Testing for Esophageal Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Molecular Testing for Esophageal Cancer revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Medical Molecular Testing for Esophageal Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Medical Molecular Testing for Esophageal Cancer revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Amoy Diagnostics, Apexhealth, Berry Oncology, Genesis Health Group, Beijing Genetron Health Technology, InMedi, KingMed Diagnostics and United Gene International, etc.

Scope of Medical Molecular Testing for Esophageal Cancer Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Medical Molecular Testing for Esophageal Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Genetic Tests

1.2.3 Biomarker Detection

1.2.4 Companion Diagnostics

1.3 Market by Application

1.3.1 Global Medical Molecular Testing for Esophageal Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Clinical Diagnosis

1.3.3 Drug Screening

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Medical Molecular Testing for Esophageal Cancer Market Perspective (2018-2029)

2.2 Global Medical Molecular Testing for Esophageal Cancer Growth Trends by Region

2.2.1 Medical Molecular Testing for Esophageal Cancer Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Medical Molecular Testing for Esophageal Cancer Historic Market Size by Region (2018-2023)

2.2.3 Medical Molecular Testing for Esophageal Cancer Forecasted Market Size by Region (2024-2029)

2.3 Medical Molecular Testing for Esophageal Cancer Market Dynamics

2.3.1 Medical Molecular Testing for Esophageal Cancer Industry Trends

2.3.2 Medical Molecular Testing for Esophageal Cancer Market Drivers

2.3.3 Medical Molecular Testing for Esophageal Cancer Market Challenges

2.3.4 Medical Molecular Testing for Esophageal Cancer Market Restraints

3.1 Global Revenue Medical Molecular Testing for Esophageal Cancer by Players

3.1.1 Global Medical Molecular Testing for Esophageal Cancer Revenue by Players (2018-2023)

3.1.2 Global Medical Molecular Testing for Esophageal Cancer Revenue Market Share by Players (2018-2023)

3.2 Global Medical Molecular Testing for Esophageal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Medical Molecular Testing for Esophageal Cancer, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Medical Molecular Testing for Esophageal Cancer Market Concentration Ratio

3.4.1 Global Medical Molecular Testing for Esophageal Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Medical Molecular Testing for Esophageal Cancer Revenue in 2022

3.5 Global Key Players of Medical Molecular Testing for Esophageal Cancer Head office and Area Served

3.6 Global Key Players of Medical Molecular Testing for Esophageal Cancer, Product and Application

3.7 Global Key Players of Medical Molecular Testing for Esophageal Cancer, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Medical Molecular Testing for Esophageal Cancer Historic Market Size by Type (2018-2023)

4.2 Global Medical Molecular Testing for Esophageal Cancer Forecasted Market Size by Type (2024-2029)

5.1 Global Medical Molecular Testing for Esophageal Cancer Historic Market Size by Application (2018-2023)

5.2 Global Medical Molecular Testing for Esophageal Cancer Forecasted Market Size by Application (2024-2029)

6.1 North America Medical Molecular Testing for Esophageal Cancer Market Size (2018-2029)

6.2 North America Medical Molecular Testing for Esophageal Cancer Market Size by Type

6.2.1 North America Medical Molecular Testing for Esophageal Cancer Market Size by Type (2018-2023)

6.2.2 North America Medical Molecular Testing for Esophageal Cancer Market Size by Type (2024-2029)

6.2.3 North America Medical Molecular Testing for Esophageal Cancer Market Share by Type (2018-2029)

6.3 North America Medical Molecular Testing for Esophageal Cancer Market Size by Application

6.3.1 North America Medical Molecular Testing for Esophageal Cancer Market Size by Application (2018-2023)

6.3.2 North America Medical Molecular Testing for Esophageal Cancer Market Size by Application (2024-2029)

6.3.3 North America Medical Molecular Testing for Esophageal Cancer Market Share by Application (2018-2029)

6.4 North America Medical Molecular Testing for Esophageal Cancer Market Size by Country

6.4.1 North America Medical Molecular Testing for Esophageal Cancer Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Medical Molecular Testing for Esophageal Cancer Market Size by Country (2018-2023)

6.4.3 North America Medical Molecular Testing for Esophageal Cancer Market Size by Country (2024-2029)

6.4.4 United States

6.4.5 Canada

7.1 Europe Medical Molecular Testing for Esophageal Cancer Market Size (2018-2029)

7.2 Europe Medical Molecular Testing for Esophageal Cancer Market Size by Type

7.2.1 Europe Medical Molecular Testing for Esophageal Cancer Market Size by Type (2018-2023)

7.2.2 Europe Medical Molecular Testing for Esophageal Cancer Market Size by Type (2024-2029)

7.2.3 Europe Medical Molecular Testing for Esophageal Cancer Market Share by Type (2018-2029)

7.3 Europe Medical Molecular Testing for Esophageal Cancer Market Size by Application

7.3.1 Europe Medical Molecular Testing for Esophageal Cancer Market Size by Application (2018-2023)

7.3.2 Europe Medical Molecular Testing for Esophageal Cancer Market Size by Application (2024-2029)

7.3.3 Europe Medical Molecular Testing for Esophageal Cancer Market Share by Application (2018-2029)

7.4 Europe Medical Molecular Testing for Esophageal Cancer Market Size by Country

7.4.1 Europe Medical Molecular Testing for Esophageal Cancer Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Medical Molecular Testing for Esophageal Cancer Market Size by Country (2018-2023)

7.4.3 Europe Medical Molecular Testing for Esophageal Cancer Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8.1 China Medical Molecular Testing for Esophageal Cancer Market Size (2018-2029)

8.2 China Medical Molecular Testing for Esophageal Cancer Market Size by Type

8.2.1 China Medical Molecular Testing for Esophageal Cancer Market Size by Type (2018-2023)

8.2.2 China Medical Molecular Testing for Esophageal Cancer Market Size by Type (2024-2029)

8.2.3 China Medical Molecular Testing for Esophageal Cancer Market Share by Type (2018-2029)

8.3 China Medical Molecular Testing for Esophageal Cancer Market Size by Application

8.3.1 China Medical Molecular Testing for Esophageal Cancer Market Size by Application (2018-2023)

8.3.2 China Medical Molecular Testing for Esophageal Cancer Market Size by Application (2024-2029)

8.3.3 China Medical Molecular Testing for Esophageal Cancer Market Share by Application (2018-2029)

9.1 Asia Medical Molecular Testing for Esophageal Cancer Market Size (2018-2029)

9.2 Asia Medical Molecular Testing for Esophageal Cancer Market Size by Type

9.2.1 Asia Medical Molecular Testing for Esophageal Cancer Market Size by Type (2018-2023)

9.2.2 Asia Medical Molecular Testing for Esophageal Cancer Market Size by Type (2024-2029)

9.2.3 Asia Medical Molecular Testing for Esophageal Cancer Market Share by Type (2018-2029)

9.3 Asia Medical Molecular Testing for Esophageal Cancer Market Size by Application

9.3.1 Asia Medical Molecular Testing for Esophageal Cancer Market Size by Application (2018-2023)

9.3.2 Asia Medical Molecular Testing for Esophageal Cancer Market Size by Application (2024-2029)

9.3.3 Asia Medical Molecular Testing for Esophageal Cancer Market Share by Application (2018-2029)

9.4 Asia Medical Molecular Testing for Esophageal Cancer Market Size by Region

9.4.1 Asia Medical Molecular Testing for Esophageal Cancer Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Medical Molecular Testing for Esophageal Cancer Market Size by Region (2018-2023)

9.4.3 Asia Medical Molecular Testing for Esophageal Cancer Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10.1 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Type

10.2.1 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Application

10.3.1 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Country

10.4.1 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11.1 Amoy Diagnostics

11.1.1 Amoy Diagnostics Company Details

11.1.2 Amoy Diagnostics Business Overview

11.1.3 Amoy Diagnostics Medical Molecular Testing for Esophageal Cancer Introduction

11.1.4 Amoy Diagnostics Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

11.1.5 Amoy Diagnostics Recent Developments

11.2 Apexhealth

11.2.1 Apexhealth Company Details

11.2.2 Apexhealth Business Overview

11.2.3 Apexhealth Medical Molecular Testing for Esophageal Cancer Introduction

11.2.4 Apexhealth Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

11.2.5 Apexhealth Recent Developments

11.3 Berry Oncology

11.3.1 Berry Oncology Company Details

11.3.2 Berry Oncology Business Overview

11.3.3 Berry Oncology Medical Molecular Testing for Esophageal Cancer Introduction

11.3.4 Berry Oncology Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

11.3.5 Berry Oncology Recent Developments

11.4 Genesis Health Group

11.4.1 Genesis Health Group Company Details

11.4.2 Genesis Health Group Business Overview

11.4.3 Genesis Health Group Medical Molecular Testing for Esophageal Cancer Introduction

11.4.4 Genesis Health Group Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

11.4.5 Genesis Health Group Recent Developments

11.5 Beijing Genetron Health Technology

11.5.1 Beijing Genetron Health Technology Company Details

11.5.2 Beijing Genetron Health Technology Business Overview

11.5.3 Beijing Genetron Health Technology Medical Molecular Testing for Esophageal Cancer Introduction

11.5.4 Beijing Genetron Health Technology Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

11.5.5 Beijing Genetron Health Technology Recent Developments

11.6 InMedi

11.6.1 InMedi Company Details

11.6.2 InMedi Business Overview

11.6.3 InMedi Medical Molecular Testing for Esophageal Cancer Introduction

11.6.4 InMedi Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

11.6.5 InMedi Recent Developments

11.7 KingMed Diagnostics

11.7.1 KingMed Diagnostics Company Details

11.7.2 KingMed Diagnostics Business Overview

11.7.3 KingMed Diagnostics Medical Molecular Testing for Esophageal Cancer Introduction

11.7.4 KingMed Diagnostics Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

11.7.5 KingMed Diagnostics Recent Developments

11.8 United Gene International

11.8.1 United Gene International Company Details

11.8.2 United Gene International Business Overview

11.8.3 United Gene International Medical Molecular Testing for Esophageal Cancer Introduction

11.8.4 United Gene International Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

11.8.5 United Gene International Recent Developments

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Medical Molecular Testing for Esophageal Cancer Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

    Table 2. Key Players of Genetic Tests

    Table 3. Key Players of Biomarker Detection

    Table 4. Key Players of Companion Diagnostics

    Table 5. Global Medical Molecular Testing for Esophageal Cancer Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

    Table 6. Global Medical Molecular Testing for Esophageal Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Medical Molecular Testing for Esophageal Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Medical Molecular Testing for Esophageal Cancer Market Share by Region (2018-2023)

    Table 9. Global Medical Molecular Testing for Esophageal Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Medical Molecular Testing for Esophageal Cancer Market Share by Region (2024-2029)

    Table 11. Medical Molecular Testing for Esophageal Cancer Market Trends

    Table 12. Medical Molecular Testing for Esophageal Cancer Market Drivers

    Table 13. Medical Molecular Testing for Esophageal Cancer Market Challenges

    Table 14. Medical Molecular Testing for Esophageal Cancer Market Restraints

    Table 15. Global Medical Molecular Testing for Esophageal Cancer Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Medical Molecular Testing for Esophageal Cancer Revenue Share by Players (2018-2023)

    Table 17. Global Top Medical Molecular Testing for Esophageal Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Molecular Testing for Esophageal Cancer as of 2022)

    Table 18. Global Medical Molecular Testing for Esophageal Cancer Industry Ranking 2021 VS 2022 VS 2023

    Table 19. Global 5 Largest Players Market Share by Medical Molecular Testing for Esophageal Cancer Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Global Key Players of Medical Molecular Testing for Esophageal Cancer, Headquarters and Area Served

    Table 21. Global Key Players of Medical Molecular Testing for Esophageal Cancer, Product and Application

    Table 22. Global Key Players of Medical Molecular Testing for Esophageal Cancer, Product and Application

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Medical Molecular Testing for Esophageal Cancer Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Medical Molecular Testing for Esophageal Cancer Revenue Market Share by Type (2018-2023)

    Table 26. Global Medical Molecular Testing for Esophageal Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Medical Molecular Testing for Esophageal Cancer Revenue Market Share by Type (2024-2029)

    Table 28. Global Medical Molecular Testing for Esophageal Cancer Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Medical Molecular Testing for Esophageal Cancer Revenue Share by Application (2018-2023)

    Table 30. Global Medical Molecular Testing for Esophageal Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Medical Molecular Testing for Esophageal Cancer Revenue Share by Application (2024-2029)

    Table 32. North America Medical Molecular Testing for Esophageal Cancer Market Size by Type (2018-2023) & (US$ Million)

    Table 33. North America Medical Molecular Testing for Esophageal Cancer Market Size by Type (2024-2029) & (US$ Million)

    Table 34. North America Medical Molecular Testing for Esophageal Cancer Market Size by Application (2018-2023) & (US$ Million)

    Table 35. North America Medical Molecular Testing for Esophageal Cancer Market Size by Application (2024-2029) & (US$ Million)

    Table 36. North America Medical Molecular Testing for Esophageal Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. North America Medical Molecular Testing for Esophageal Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 38. North America Medical Molecular Testing for Esophageal Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Europe Medical Molecular Testing for Esophageal Cancer Market Size by Type (2018-2023) & (US$ Million)

    Table 40. Europe Medical Molecular Testing for Esophageal Cancer Market Size by Type (2024-2029) & (US$ Million)

    Table 41. Europe Medical Molecular Testing for Esophageal Cancer Market Size by Application (2018-2023) & (US$ Million)

    Table 42. Europe Medical Molecular Testing for Esophageal Cancer Market Size by Application (2024-2029) & (US$ Million)

    Table 43. Europe Medical Molecular Testing for Esophageal Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Europe Medical Molecular Testing for Esophageal Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Europe Medical Molecular Testing for Esophageal Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 46. China Medical Molecular Testing for Esophageal Cancer Market Size by Type (2018-2023) & (US$ Million)

    Table 47. China Medical Molecular Testing for Esophageal Cancer Market Size by Type (2024-2029) & (US$ Million)

    Table 48. China Medical Molecular Testing for Esophageal Cancer Market Size by Application (2018-2023) & (US$ Million)

    Table 49. China Medical Molecular Testing for Esophageal Cancer Market Size by Application (2024-2029) & (US$ Million)

    Table 50. Asia Medical Molecular Testing for Esophageal Cancer Market Size by Type (2018-2023) & (US$ Million)

    Table 51. Asia Medical Molecular Testing for Esophageal Cancer Market Size by Type (2024-2029) & (US$ Million)

    Table 52. Asia Medical Molecular Testing for Esophageal Cancer Market Size by Application (2018-2023) & (US$ Million)

    Table 53. Asia Medical Molecular Testing for Esophageal Cancer Market Size by Application (2024-2029) & (US$ Million)

    Table 54. Asia Medical Molecular Testing for Esophageal Cancer Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 55. Asia Medical Molecular Testing for Esophageal Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 56. Asia Medical Molecular Testing for Esophageal Cancer Market Size by Region (2024-2029) & (US$ Million)

    Table 57. Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Type (2018-2023) & (US$ Million)

    Table 58. Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Type (2024-2029) & (US$ Million)

    Table 59. Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Application (2018-2023) & (US$ Million)

    Table 60. Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Application (2024-2029) & (US$ Million)

    Table 61. Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 62. Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 63. Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 64. Amoy Diagnostics Company Details

    Table 65. Amoy Diagnostics Business Overview

    Table 66. Amoy Diagnostics Medical Molecular Testing for Esophageal Cancer Product

    Table 67. Amoy Diagnostics Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023) & (US$ Million)

    Table 68. Amoy Diagnostics Recent Developments

    Table 69. Apexhealth Company Details

    Table 70. Apexhealth Business Overview

    Table 71. Apexhealth Medical Molecular Testing for Esophageal Cancer Product

    Table 72. Apexhealth Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023) & (US$ Million)

    Table 73. Apexhealth Recent Developments

    Table 74. Berry Oncology Company Details

    Table 75. Berry Oncology Business Overview

    Table 76. Berry Oncology Medical Molecular Testing for Esophageal Cancer Product

    Table 77. Berry Oncology Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023) & (US$ Million)

    Table 78. Berry Oncology Recent Developments

    Table 79. Genesis Health Group Company Details

    Table 80. Genesis Health Group Business Overview

    Table 81. Genesis Health Group Medical Molecular Testing for Esophageal Cancer Product

    Table 82. Genesis Health Group Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023) & (US$ Million)

    Table 83. Genesis Health Group Recent Developments

    Table 84. Beijing Genetron Health Technology Company Details

    Table 85. Beijing Genetron Health Technology Business Overview

    Table 86. Beijing Genetron Health Technology Medical Molecular Testing for Esophageal Cancer Product

    Table 87. Beijing Genetron Health Technology Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023) & (US$ Million)

    Table 88. Beijing Genetron Health Technology Recent Developments

    Table 89. InMedi Company Details

    Table 90. InMedi Business Overview

    Table 91. InMedi Medical Molecular Testing for Esophageal Cancer Product

    Table 92. InMedi Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023) & (US$ Million)

    Table 93. InMedi Recent Developments

    Table 94. KingMed Diagnostics Company Details

    Table 95. KingMed Diagnostics Business Overview

    Table 96. KingMed Diagnostics Medical Molecular Testing for Esophageal Cancer Product

    Table 97. KingMed Diagnostics Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023) & (US$ Million)

    Table 98. KingMed Diagnostics Recent Developments

    Table 99. United Gene International Company Details

    Table 100. United Gene International Business Overview

    Table 101. United Gene International Medical Molecular Testing for Esophageal Cancer Product

    Table 102. United Gene International Revenue in Medical Molecular Testing for Esophageal Cancer Business (2018-2023) & (US$ Million)

    Table 103. United Gene International Recent Developments

    Table 104. Research Programs/Design for This Report

    Table 105. Key Data Information from Secondary Sources

    Table 106. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Medical Molecular Testing for Esophageal Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 2. Global Medical Molecular Testing for Esophageal Cancer Market Share by Type: 2022 VS 2029

    Figure 3. Genetic Tests Features

    Figure 4. Biomarker Detection Features

    Figure 5. Companion Diagnostics Features

    Figure 6. Global Medical Molecular Testing for Esophageal Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 7. Global Medical Molecular Testing for Esophageal Cancer Market Share by Application: 2022 VS 2029

    Figure 8. Clinical Diagnosis Case Studies

    Figure 9. Drug Screening Case Studies

    Figure 10. Medical Molecular Testing for Esophageal Cancer Report Years Considered

    Figure 11. Global Medical Molecular Testing for Esophageal Cancer Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Medical Molecular Testing for Esophageal Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Medical Molecular Testing for Esophageal Cancer Market Share by Region: 2022 VS 2029

    Figure 14. Global Medical Molecular Testing for Esophageal Cancer Market Share by Players in 2022

    Figure 15. Global Top Medical Molecular Testing for Esophageal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Molecular Testing for Esophageal Cancer as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Medical Molecular Testing for Esophageal Cancer Revenue in 2022

    Figure 17. North America Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Medical Molecular Testing for Esophageal Cancer Market Share by Type (2018-2029)

    Figure 19. North America Medical Molecular Testing for Esophageal Cancer Market Share by Application (2018-2029)

    Figure 20. North America Medical Molecular Testing for Esophageal Cancer Market Share by Country (2018-2029)

    Figure 21. United States Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Medical Molecular Testing for Esophageal Cancer Market Size YoY (2018-2029) & (US$ Million)

    Figure 24. Europe Medical Molecular Testing for Esophageal Cancer Market Share by Type (2018-2029)

    Figure 25. Europe Medical Molecular Testing for Esophageal Cancer Market Share by Application (2018-2029)

    Figure 26. Europe Medical Molecular Testing for Esophageal Cancer Market Share by Country (2018-2029)

    Figure 27. Germany Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. France Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. U.K. Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Italy Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Russia Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Nordic Countries Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. China Medical Molecular Testing for Esophageal Cancer Market Size YoY (2018-2029) & (US$ Million)

    Figure 34. China Medical Molecular Testing for Esophageal Cancer Market Share by Type (2018-2029)

    Figure 35. China Medical Molecular Testing for Esophageal Cancer Market Share by Application (2018-2029)

    Figure 36. Asia Medical Molecular Testing for Esophageal Cancer Market Size YoY (2018-2029) & (US$ Million)

    Figure 37. Asia Medical Molecular Testing for Esophageal Cancer Market Share by Type (2018-2029)

    Figure 38. Asia Medical Molecular Testing for Esophageal Cancer Market Share by Application (2018-2029)

    Figure 39. Asia Medical Molecular Testing for Esophageal Cancer Market Share by Region (2018-2029)

    Figure 40. Japan Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. South Korea Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. China Taiwan Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Southeast Asia Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. India Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Australia Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Size YoY (2018-2029) & (US$ Million)

    Figure 47. Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Share by Type (2018-2029)

    Figure 48. Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Share by Application (2018-2029)

    Figure 49. Middle East, Africa, and Latin America Medical Molecular Testing for Esophageal Cancer Market Share by Country (2018-2029)

    Figure 50. Brazil Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 51. Mexico Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 52. Turkey Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 54. Israel Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 55. GCC Countries Medical Molecular Testing for Esophageal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 56. Amoy Diagnostics Revenue Growth Rate in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

    Figure 57. Apexhealth Revenue Growth Rate in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

    Figure 58. Berry Oncology Revenue Growth Rate in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

    Figure 59. Genesis Health Group Revenue Growth Rate in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

    Figure 60. Beijing Genetron Health Technology Revenue Growth Rate in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

    Figure 61. InMedi Revenue Growth Rate in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

    Figure 62. KingMed Diagnostics Revenue Growth Rate in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

    Figure 63. United Gene International Revenue Growth Rate in Medical Molecular Testing for Esophageal Cancer Business (2018-2023)

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed